Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Sanofi
02 7Orion Corporation
03 4Dr. Reddy's Laboratories
04 51A Pharma Gmbh
05 32care4
06 23M Health Care
07 2AMW GmbH
08 1Ababor Pharmaceuticals Sl
09 2Abacus Medicine
10 2Acino Pharma
11 4Actavis Inc
12 4Alembic Pharmaceuticals Limited
13 8Almirall
14 8Apotex Inc
15 4Arrow Aps
16 8Aurobindo Pharma Limited
17 4Chartwell Pharmaceuticals llc
18 1Cinfa
19 5Combix Laboratories Slu
20 5ELPEN Pharmaceutical
21 5Ebb Medical
22 5Farmalider SA
23 4GENERIC MEDICAL PARTNERS INC
24 1Galenicum
25 5Hexal AG
26 8JAMP PHARMA
27 9Karo Pharma
28 5Kern Pharma S.L.
29 5Knight Therapeutics
30 17Krka
31 4LABORATORIOS NORMON SA
32 2Luye Pharma
33 4Macleods Pharmaceuticals Limited
34 1Medartuum
35 3Mepha Pharma
36 21Novartis Pharmaceuticals Corporation
37 7ORIFARM GROUP AS
38 4OrBion Pharmaceuticals
39 4Pharmascience Inc.
40 4Ratiopharm GmbH
41 13STADA Arzneimittel
42 25Sandoz B2B
43 5Sun Pharmaceutical Industries Limited
44 5Synthon Pharmaceuticals
45 7Teva Pharmaceutical Industries
46 1Torrefarma
47 5Unichem Laboratories Limited
48 1Vegal Farmaceutica Sl
49 6Viatris
50 2Vir Sa Chemical And Pharmaceutical Industry
51 5World Medicine
52 4Zydus Lifesciences
01 32CAPSULE
02 44CAPSULE;ORAL
03 80Capsule
04 42Hard Capsule
05 1ORAL SOLUTION
06 19Oral Solution
07 4Orodispersible Tablet
08 1SOLUTION
09 1SOLUTION; ORAL
10 1SOLUTION;ORAL
11 54Transdermal Patch
01 19Allowed
02 67Approved
03 38Authorized
04 11Cancelled
05 13DISCN
06 55Deregistered
07 10Generic
08 29Prescription
09 32RX
10 4Suspensed
11 1Blank
01 4APO-RIVASTIGMINE
02 2Aldemyl
03 10EXELON
04 3Emerpand
05 13Exelon
06 3Exelon Patch
07 4JAMP RIVASTIGMINE
08 4JAMP RIVASTIGMINE CAPSULES
09 4MED-RIVASTIGMINE
10 17Nimvastid
11 3Orivast
12 4PMS-RIVASTIGMINE
13 8Prometax
14 1RIVASTIGMINE
15 40RIVASTIGMINE TARTRATE
16 3Rigmin
17 2Rivastigmin Abacus Medicine
18 4Rivastigmin Mylan
19 4Rivastigmin Ratiopharm
20 4Rivastigmin Stada
21 4Rivastigmina Aurobindo
22 1Rivastigmina Cinfa
23 5Rivastigmina Combix
24 5Rivastigmina Farmalider
25 1Rivastigmina Galenicum Derma
26 5Rivastigmina Kern Pharma
27 1Rivastigmina Montvel
28 1Rivastigmina Ortodrol
29 10Rivastigmina Sandoz
30 4Rivastigmina Stadafarma
31 1Rivastigmina Torrefarma
32 1Rivastigmina Vir
33 5Rivastigmine 1 A Pharma
34 2Rivastigmine 3M Health Care Ltd.
35 1Rivastigmine Ababor
36 2Rivastigmine Acino
37 6Rivastigmine Actavis
38 2Rivastigmine Amw
39 4Rivastigmine Arrow
40 1Rivastigmine Ebb
41 5Rivastigmine Hexal
42 1Rivastigmine Medartuum
43 4Rivastigmine Normon
44 4Rivastigmine Orifarm
45 11Rivastigmine Orion
46 3Rivastigmine Patch Sandoz
47 5Rivastigmine Sandoz
48 2Rivastigmine Stada
49 3Rivastigmine Stada Medicines
50 5Rivastigmine Synthon
51 7Rivastigmine Teva
52 3Rivastigmine Zentiva Patch h
53 3Rivastigmine-Mepha Patch h
54 3Rivastor
55 2Rivasur twice weekly hours
56 4SANDOZ RIVASTIGMINE
57 5Telomena
58 10Blank
01 29Canada
02 5India
03 53Spain
04 122Sweden
05 19Switzerland
06 5Turkey
07 46USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 4.6mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 13.3mg/24hours
Packaging :
Approval Date : 15/01/2020
Application Number : 20181221000018
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE TARTRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1.5MG BASE
Packaging :
Approval Date : 2007-10-31
Application Number : 77130
Regulatory Info : RX
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 9.5mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 13.3mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 4.6mg/24hours
Packaging :
Approval Date : 13/06/2013
Application Number : 20110507000046
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 9.5mg/24hours
Packaging :
Approval Date : 13/06/2013
Application Number : 20110507000053
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength : 1.5mg
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000025
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000049
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength : 4.5mg
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000056
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000063
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE TARTRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 3MG BASE
Packaging :
Approval Date : 2007-10-31
Application Number : 77130
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE TARTRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 4.5MG BASE
Packaging :
Approval Date : 2007-10-31
Application Number : 77130
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RIVASTIGMINE TARTRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 6MG BASE
Packaging :
Approval Date : 2007-10-31
Application Number : 77130
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)
Brand Name : EXELON
Dosage Form : CAPSULE
Dosage Strength : 3MG
Packaging : 56/60
Approval Date :
Application Number : 2242116
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)
Brand Name : EXELON
Dosage Form : CAPSULE
Dosage Strength : 4.5MG
Packaging : 56/60
Approval Date :
Application Number : 2242117
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)
Brand Name : EXELON
Dosage Form : CAPSULE
Dosage Strength : 6MG
Packaging : 56/60
Approval Date :
Application Number : 2242118
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EXELON
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2000-04-21
Application Number : 20823
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EXELON
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2000-04-21
Application Number : 20823
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EXELON
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2000-04-21
Application Number : 20823
Regulatory Info : DISCN
Registration Country : USA
Contact Us!
